-
About UsBeijing Northland Biotechnology Co., Ltd. is an innovative biopharmaceutical company specializing in the research, development, production, and sales of gene therapy drugs, recombinant protein drugs, and ophthalmic drugs. -
R&D and ProductsPrimarily dedicated to the research, development, and industrialization of novel bioengineered drugs in areas such as cardiovascular diseases, metabolic disorders, rare diseases, and ophthalmic diseases. -
Investor RelationsGuided by the principle of “Creating Value, Serving Health,” the company is committed to becoming an innovative biopharmaceutical enterprise, contributing to the advancement of China’s pharmaceutical industry and the well-being of humanity.
NORTHLAND Selected for the Third Batch of Tsinghua Science Park's "Diamond Program"
From October 27 to 28, 2010, the 2nd Qidi Innovation Forum (Guanlin) and the 2010 Qidi National Branch Network Annual Conference were grandly held in Guanlin, Yixing. At the closing ceremony of the forum on the afternoon of the 28th, Tsinghua Science Park presented plaques to eight companies—including Beijing Northland Biotechnology Co., Ltd.—that had been selected for the third batch of the Diamond Program of Tsinghua Science Park.
http://www.spmember.com/News/News.aspx?newsID=4751
Share to:
Friendly Links: Baidu | NORTHLAND
Contact Information
Address: Room A406, Zhongguancun Biomedical Park, No. 5 Kaituo Road, Shangdi, Haidian District, Beijing
Follow Us
Northland is an innovative biopharmaceutical company specializing in the R&D, manufacturing and sales of gene therapy drugs, recombinant protein drugs and ophthalmic medications.
Web site
NL-BIO
NL003
NL005